90097-45-3 Usage
General Description
3-Hydroxymethyl-1H-quinolin-2-one is a chemical compound with the molecular formula C10H9NO2. It is a quinolinone derivative with a hydroxymethyl group attached to the quinoline ring. 3-HYDROXYMETHYL-1H-QUINOLIN-2-ONE has potential applications in medicinal chemistry, as it has been investigated for its antibacterial and antifungal properties. It has also been studied for its potential as a chelating agent and as a building block in organic synthesis. Additionally, 3-hydroxymethyl-1H-quinolin-2-one has been explored for its potential as a fluorescent dye and as a ligand in coordination chemistry. Overall, this compound has diverse potential applications and warrants further investigation for its various uses in pharmaceuticals, materials science, and chemical research.
Check Digit Verification of cas no
The CAS Registry Mumber 90097-45-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,0,9 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 90097-45:
(7*9)+(6*0)+(5*0)+(4*9)+(3*7)+(2*4)+(1*5)=133
133 % 10 = 3
So 90097-45-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H9NO2/c12-6-8-5-7-3-1-2-4-9(7)11-10(8)13/h1-5,12H,6H2,(H,11,13)
90097-45-3Relevant articles and documents
Design of new quinolin-2-one-pyrimidine hybrids as sphingosine kinases inhibitors
Abonia, Rodrigo,Andújar, Sebastián,Cobo, Justo,Enriz, Ricardo D.,Gutiérrez, Lucas,Insuasty, Daniel,Lima, Santiago,Marchal, Antonio,Nogueras, Manuel,Spiegel, Sarah,Vettorazzi, Marcela
, (2019/12/09)
Sphingosine-1-phosphate is now emerging as an important player in cancer, inflammation, autoimmune, neurological and cardiovascular disorders. Abundance evidence in animal and humans cancer models has shown that SphK1 is linked to cancer. Thus, there is a
Carbostyril derivatives
-
, (2008/06/13)
Disclosed are carbostyril derivatives and their salts of the formulas STR1 The compounds have anti-peptic ulcer effects, and are useful as a treating agent for curing peptic ulcers in the digestive system, such as ulcers in the stomach and in the duodenum. The compounds particularly have prophylaxis and curing effects for treating chronic ulcers, for example experimental acetic acid-induced ulcers and cautery ulcers, with both low toxicity and few side-effects. Also disclosed are processes for preparing the compounds and for preparing pharmaceutical compositions containing them.
